Short Interest Worth Mentioning: Ventas Incorporated (NYSE:VTR) Has Decline in Shorts

November 21, 2016 - By Marie Mckinney   ·   0 Comments

Short Interest Worth Mentioning: Ventas Incorporated (NYSE:VTR) Has Decline in Shorts

The stock of Ventas Incorporated (NYSE:VTR) registered a decrease of 0.95% in short interest. VTR’s total short interest was 8.74M shares in November as published by FINRA. Its down 0.95% from 8.83 million shares, reported previously. With 2.77 million shares average volume, it will take short sellers 3 days to cover their VTR’s short positions. The short interest to Ventas Incorporated’s float is 2.5%. The stock increased 0.03% or $0.02 on November 18, hitting $59.9. About 15 shares traded hands. Ventas, Inc. (NYSE:VTR) has declined 6.30% since April 19, 2016 and is downtrending. It has underperformed by 10.16% the S&P500.

Ventas, Inc. is a healthcare real estate investment trust with its properties located throughout the United States, Canada and the United Kingdom. The company has a market cap of $21.33 billion. The Firm operates through three divisions: triple-net leased properties, senior living activities and MOB operations. It has a 38.57 P/E ratio. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom.

Insitutional Activity: The institutional sentiment increased to 1.33 in 2016 Q2. Its up 0.07, from 1.26 in 2016Q1. The ratio is positive, as 40 funds sold all Ventas, Inc. shares owned while 189 reduced positions. 58 funds bought stakes while 231 increased positions. They now own 309.67 million shares or 1.99% less from 315.96 million shares in 2016Q1.
Schwab Charles Management accumulated 0.21% or 2.28 million shares. Inv Centers Of America has 19,169 shares for 0.27% of their US portfolio. Cornerstone Advisors holds 53 shares or 0% of its portfolio. Cap Guardian Trust accumulated 0% or 135 shares. Ameritas Invest Prtn Incorporated has 6,685 shares for 0.03% of their US portfolio. Moreover, Parkwood has 0.1% invested in Ventas, Inc. (NYSE:VTR) for 7,978 shares. The Vermont-based Tru Of Vermont has invested 0.01% in Ventas, Inc. (NYSE:VTR). Boston Private Wealth Ltd Liability Corp last reported 0.09% of its portfolio in the stock. Sawtooth Asset Mgmt Incorporated owns 4,332 shares or 0.17% of their US portfolio. Tradewinds Cap Management Ltd reported 250 shares or 0.01% of all its holdings. Toronto Dominion National Bank holds 1,848 shares or 0% of its portfolio. Cypress Capital Group has invested 0.05% of its portfolio in Ventas, Inc. (NYSE:VTR). Dekabank Deutsche Girozentrale accumulated 0.01% or 12,066 shares. Bb&T has invested 0.09% of its portfolio in Ventas, Inc. (NYSE:VTR). Employees Retirement Association Of Colorado reported 74,444 shares or 0.04% of all its holdings.

Insider Transactions: Since August 2, 2016, the stock had 0 insider purchases, and 4 insider sales for $18.19 million net activity. Cobb John D. sold $4.50 million worth of stock. Shares for $12.37 million were sold by RINEY T RICHARD on Tuesday, August 16. On Friday, August 12 CAFARO DEBRA A sold $807,562 worth of the stock or 10,757 shares. Liebbe Gregory R also sold $508,225 worth of Ventas, Inc. (NYSE:VTR) shares.

Ventas, Inc. (NYSE:VTR) Ratings Coverage

Out of 12 analysts covering Ventas Inc. (NYSE:VTR), 1 rate it a “Buy”, 0 “Sell”, while 11 “Hold”. This means 8% are positive. Ventas Inc. has been the topic of 30 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Mizuho downgraded the shares of VTR in a report on Monday, November 21 to “Neutral” rating. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, January 6. The firm earned “Neutral” rating on Thursday, August 25 by BTIG Research. BMO Capital Markets downgraded Ventas, Inc. (NYSE:VTR) rating on Thursday, November 10. BMO Capital Markets has “Market Perform” rating and $55 price target. On Tuesday, August 23 the stock rating was maintained by UBS with “Neutral”. The firm has “Outperform” rating given on Monday, July 27 by BMO Capital Markets. The company was initiated on Wednesday, July 13 by Argus Research. As per Wednesday, November 11, the company rating was maintained by Mizuho. The firm has “Equal Weight” rating by Barclays Capital given on Monday, May 2. The company was maintained on Friday, September 4 by Mizuho.

VTR Company Profile

Ventas, Inc., incorporated on June 22, 1987, is a healthcare real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Firm operates through three divisions: triple-net leased properties, senior living activities and medical office building (MOB) operations. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom. Through its senior living activities segment, the Company invests in seniors housing communities throughout the United States and Canada, and engages independent operators to manage approximately 304 of its seniors housing communities. In its MOB activities segment, the Company primarily acquires, owns, develops, leases and manages MOBs. The Firm primarily invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operates them through independent third-party managers. It leases approximately 575 properties to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures.

More recent Ventas, Inc. (NYSE:VTR) news were published by: Reuters.com which released: “BRIEF-Kindred announces agreements with Ventas Inc” on November 14, 2016. Also Seekingalpha.com published the news titled: “What Does ‘TrumpCare’ Mean For Ventas?” on November 14, 2016. Seekingalpha.com‘s news article titled: “Ventas: A High-Yield, High Quality Healthcare REIT” with publication date: November 15, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marie Mckinney


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>